methods or by delivery of pharmacologic substances to the target region .
Catheter ablative procedures at present involve delivery of energy pulses by means of electrode catheters of the standard type used for electrophysiologic studies or as modified with larger surface area tips and other design features . Radiofrequency has largely replaced direct current shock as the energy source . The methods of procedure vary depending on the type of arrhythmia treated and include ablation of the AV junction, modification of the AV node or perinodal areas, ablation of accessory AV pathways and ablation of atrial or ventricular tissue . Ablation of the AV junction to produce complete AV block involves insertion of an electrode catheter in the region of the AV junction with delivery of radiofrequency current to interrupt impulse transmission from atrium to ventricle . Modification of the AV node is used to eliminate AV node reentrant tachycardia while leaving AV node conduction intact. For patients with accessory AV connections, the catheter is placed in close approximation to the accessory pathway to desiccate this tissue by delivery of radiofrequency energy pulses . After appropriate mapping and localization of sites of ectopic impulse formation or location of the right bundle branch in cases of bundle branch reentrant ventricular tachycardia, radiofrequency pulses can be delivered to terminate the tachycardia . A detailed report (2) by the Diagnostic and Therapeutic Technology Assessm :nt panel (DATTA) of the American Medical Association can be reviewed .
Safety and Efficacy of Catheter Ablative Procedures
Catheter ablation was first used clinically in 1981 and initially involved use of high energy direct current shocks for destruction of the AV junction . Ablative procedures hava been 0735-1197/94/S7.00 Efficacy and safety of direct current shocks for AV junctional ablation . Sixty-four percent of patients who achieved third-degree AV block remain without symptoms or need for antiarrhythmic therapy (4) . However, long-term cardiac pacing is required. Eight percent of patients had return of conduction but with arrhythmia control without symptoms and without requiring an antiarrhythmic drug (4). Ablation therapy was considered to have failed in 16% of patients (4).
Acute major complications of high energy direct current ablation are rare but include induction of ventricular arrhythmias, myocardial perforation, venous thrombosis and myocardial depression . The most seriow in-hospital complication is polymorphous ventricular tachycardia and occurs in -4% of patients . The most serious reported complication is a 1 .8% incidence of sudden cardiac death, which may occur from 3 days to 6 months after ablation (4) . The causal relation of the ablative procedure itself and sudden death is unclear . Longterm outcomes, including proarrhythmia assessment, have been described (7, 8) . Notably, direct current shocks for ablative procedures have now been largely supplanted by radiofrequency technology Direct current shocks may still be useful in some instances, especially if radiofrequency fails (9,10), and some developmental work in direct current ablation continues (11) .
Results of radiofrequency ablation of the AVjunction . The reported efficacy of radiofrequency ablation for the AV junction varies from 70% to 95% (5, 6, 9, 10, 12, 13 Results of catheter ablation of accessory AV connections .
The worldwide experience using direct current ablation or destruction of accessory AV connections has been summarized (2,4) . The largest reported series using direct current ablation was reported by Warin et al . (15), who reported a 96% success rate in 246 consecutive patients . Significant complications included a 2% incidence of cardiac tamponade and a 2%
incidence of sudden death ; four patients required permanent cardiac pacemakers (15) .
Radiofrequency energy has largely supplanted high energy direct current shocks for ablation of accessory AV connections Results of AV node modification in patients with AV node reentrant tachycardia. Initial reports described the use of high energy direct current discharges in patients with AV node reentry (22,23) . Efficacy in terms of tachycardia cure was -85%, but the procedure was associated with a 5% to 10%
incidence of AV block in the initial reports . Selective ablation of the slow AV node pathway appears to reduce the risk of complete AV block to :52% to 3% (6) . More recently, other groups have described using radiofrequency energy for AV resulting in tachycardia cure without producing third-degree AV block . The procedure was found to be successful in 85% to 99% of patients . The chief complication reported was induction of complete AV block which, as in other series (28) , occurred much more frequently in those patients who underwent attempted fast pathway ablation. The 1992 NASPE survey (6) included 3,052 patients undergoing slow pathway ablation, with success in 96% and successful fast pathway ablation in 90% of 255 patients . Overall complications were 0.96%, and no procedure-related deaths were reported . Atrial tachycardia and flutter . In the NASPE survey (6) the success rate was 75% in 371 patients with atrial tachycardia and flutter. The majority of the successes were due to elimination of these arrhythmias. and the remainder included control of the ventricular rate by AV node modification or ablation . There was a 0.81'' complication rate and no reported deaths .
Chronic atrial tachycardia frequently leading to cardiomyopathy has been successfully and permanently eradicated by radiofrequency catheter ablation in 12 young patients (32) . Successes arc being reported in ablations for atrial (5, 33, 34) and sinus node tachycardias (5,34) in adults .
Radiofrequency catheter ablation has successfully terminated and prevented arrhythmia reinduction in the presence of type I atrial flutter in humans (5, 35) . In these subjects an area of slow conduction in the low posteroseptal right atrium was directly ablated . In some patients, activation mapping of atrial flutter revealed a counterclockwise reentrant wavefront originating just interior or posterior to the coronary sinus ostium, proceeding sispe' lorly in the atrial septum to the right atrial free wall, inferiorly toward the tricuspid annulus and, finally, medially between the inferior vena cava and tricuspid annulus . The ablation sites were located just inferior or posterior to the coronary sinus ostium and were characterized by discrete clectrograms before the P wave (35) . Ventricular tachycardia . Several reports (6,36-41) have described the success of radiofrequency current catheter ablation in patients with sustained ventricular tachycardia. In addition to coronary artery disease-related ventricular tachycardia, this technique has been used in patients with sustained ventricular tachycardia in the presence of bundle branch reentrant tachycardia (37,38) right ventricular outflow tract tachycardia (39) and other idiopathic ventricular tachycardias (40, 41) .
In the NASPE survey (6) there were 429 patients with ventricular tachycardia with a successful ablation rate of 71% overall ; 85% in 224 with structurally normal hearts; 54% in 115 with ischemic disease : and 61% with idiopathic cardiomyopathy . Complications occurred in 3%, with no reported deaths .
Clinical Applications
Catheter ablation of the AV junction is currently considered the procedure of choice for patients with drug-resistant arrhythmias arising from atrial tissue and poorly controlled ventricular rates, unless primary ablation of the tachycardia JA('(' Vol. _' 4. No . September 1994 :825-33 focus is possible . Similarly, catheter ablation of the accessory AV connection is the procedure of choice for patients with drug-resistant accessory pathway-mediated tachycardias. The remarkable efficacy and safety of the latter procedure allows extension of its use for patients with symptomatic tachycardias (involving an accessory connection) who refuse long-term dependence on drug therapy or have drug intolerance . Catheter modification of the AV node is the procedure of choice for patients intolerant to drugs or with drug-resistant AV node reentrant tachycardia and may he used in preference to long-term dependence on drug therapy for symptomatic patients with AV node reentry . This procedure is clearly preferable to surgery in terms of risk, expense . pain and other discomfort. With the further relinements in catheter mapping, radiofrequency ablation for atrial and ventricular Iachyarrhythmias is now possible .
These recommendations are supported by a recent state of (heart statement by the Subcommittee on l lectrocardiography and Electrophysiology of the American Heart Association (42), a NASPE policy statement of which this is an update (1). peer-reviewed published reports (43 .44 land many others, see References]), extensive survey data (6) and major textbooks of cardiology (45-47).
Comparison With Other Techniques or Procedures
Alternative therapy includes use of drugs for tachycardia control, antitachycardia pacing, Impiantahle cardioverterdelibrillators and direct cardiac surgical ablation . Heretofore, cardiac surgery has been considered the treatment of choice for patients with drug-resistant supraventricular arrhvthmias (48, 49) . Cardiac surgery is very effective but requires an open heart procedure, a hospital stay of 5 to 8 days and prolonged convalescence until complete recovery is achieved . Catheter ablation is preferable to surgery in patients with drsiC-resistant arrhythmias arising from atrial tissue because it is associated with lower immediate morbidity and mortality and costs much less than surgery . Catheter ablation in patients with accessory pathway-mediated tachycardia or AV node reentrant arrhythmia is curative and thus obviates long-term need for drug therapy . The catheter approach involves a short hospital stay, after which the patient resumes normal activities . The hospital stay can be <_ 1 day in ideal cases, although this is not yet typical because newly diagnosed and complex cases and those that require monitoring during drug washout or next-day confirmation electrophysiologic studies all may require a longer hospital stay .
Drug therapy in patients with resistant arrhythmias who require multiple drugs may he expensive, especially when factored over the projected life of younger patients. and are often associated with adverse effects . Many of the available drugs are not suitable for pregnant women because of the potential for teratogenic effects. Drugs often require meticulous attention to proper timing and dosage because missing or altering a single dose may place the patient at risk for recurrent arrhythmias, and many patients are averse to long-term dependence on drug therapy . Antitachycardia pacing is seldom used today for treatment of supraventricular tachycardias because 1) it does not eliminate the arrhythmia, and patients remain symptomatic from their arrhythmias or during pacing induced termination ; 2) it tends to become ineffective during long-term follow-up (50) ; and 3) application of antitachycardia pacing puts the patient at risk for induction of atrial fibrillation or atrial flutter, which may result in life-threatening arrhythmias for patients with Wolff-Parkinson-White syndrome .
Cost Considerations
Catheter ablation is cost-effective (21, 25) . Most supraventricular tachycardias involve a brief hospital stay in a unit with electrocardiographic monitoring facilities . Initial diagnostic and, in some patients, follow-up studies to document successful ablation are also required and may he performed at a referring institution . The total cost of the ablative procedure itself, including the physician fee, ranges from $12,000 to $18,000 . This is approximately one-third the total cost of surgical treatment (51) .
The length of the ablative procedure, including electrophysiologic assessment, averages 3 to 6 h but can take > 12 h . Considering the training, expertise and time required for catheter ablation, the physician compensation is substantially less than current rates for comparable intehventional techniques, such as coronary balloon angioplasty . It should be further emphasized that there is a >90% rate of permanent cure with the most commonly used catheter ablative procedures (AV junctional modification and accessory pathway ablation) .
Unanswered Questions and Future Research
Future research will involve development of better mapping techniques and catheters with better electrode configurations and improved steerability to allow easier access to sites of accessory AV connections. In addition, future clinical and research efforts will focus on refinement of radiofrequency energy ; additional energy sources; more effective ablation of arrhythmias, such as ventricular tachycardia, to improve the safety and efficacy of these procedures ; and extension to other arrhythmias, including atrial fibrillation . The potential longterm risks of radiation exposure sometimes required for lengthy procedures need to be more fully assessed (52, 53) .
There is need for long-term surveillance of efficacy and safety of patients undergoing catheter ablation, just as there is for other forms of therapy, including drugs, surgery and devices. of training for electrophysiology board eligibility . Extrapolating from published guidelines for general training in clinical clectrophysiology (54) and the NASPE and ACC committees were in accord that the physician should have been the primary operator for a minimum of 30 catheter ablation procedures, including at least 15 accessory AV connection ablations . It was considered desirable that two physicians be involved in complex catheter ablation procedures, particularly those involving ablation of accessory pathways or ventricular tachycardia. The second physician need not be a trained electrophysiologist but should be adept in catheter manipulation and treatment of cardiac emergencies . A cardiology or electrophysiology postdoctoral fellow or specially trained registered nurse or physician assistant could fill this role .
To ensure good quality and continued competence, 1) the committees considered that the physician should perform ?20 ablative procedures/year, an impression backed by data from the NASPE survey (6) showing a significantly higher complication rate in centers performing <20 ablations/year. Anticipated success rates should be at Ica'st 80%% for AV junctional ablation, AV node modification for AV node reentry and accessory pathway ablation . The success rate for ventricular tachycardia should be at least 30% hut is highly dependent on patient selectioa .
Laboratory personnel . Laboratory personnel should include two nurses (or technicians) . One nurse (or physician assistant) is required to administer sedation and carefully monitor vital signs throughout the procedure . The NASPE and ACC committees considered that ablation procedures should only be performed in centers with ready availability of cardiac surgical support and percutaneous transluminal coronary angioplasty teams . It was considered that a cardiac surgeon or anesthesiologist need not he present but should be available for emergencies. It is not necessary to perform these procedures in the operating room .
Facilities and equipment . Ablative procedures should be performed in a facility set up for invasive electrophysiologic studies . The minimal standards for X-ray equipment should constitute a rotatable C arm or table with good quality X-ray image. A video recording system for fluoroscopic images is recommended . Biplane X-ray equipment is considered to be desirable but not absolutely necessary . State of the art roentgenographic equipment is favored to minimize radiation exposure, and duration of radiation should be carefully logged for all procedures. It was considered that the laboratory should establish guidelines for total radiation exposure for these procedures (52, 53) . A recent study showed that the highest exposure of radiation was to the posterior ninth thoracic vertebral body, which received an average of -19 rads (52) . Radiation experts consider that this degree of exposure would be associated with a lifetime excess risk of fatal malignancy of -1/1,000 of dying of a malignancy during their lifetime . It should be noted that the background risk of dying of a malignancy is 200/1,000 for a 35-year old person . This level of risk was thought to be lower than the risk of alternative medical or surgical treatment (52) . The laboratory should be equipped to care for patients with acute coronary complications (e .g ., thrombus, coronary artery spasm, cardiac tamponade, coronary dissection). In addition, facilities for both temporary and permanent pacemaker insertion should be available.
It is recommended that the devices used for such ablation procedures be utilized in a manner conforming to hospital, local and national regulations governing their application . Recommendations 1 . Catheter ablation of the AV junction is recommended as the procedure of choice in patients with drug-resistant symptomatic atrial tachyarrhythmias and uncontrolled ventricular rates, when complete AV block is the therapy of choice . 2 . Catheter ablation of accessory pathway or pathways is the treatment of choice in patients with drug-intolerant or drug-resistant arrhythmias mediated by accessory pathways . 3 . Catheter modification of the AV junction, particularly using the slow pathway approach, is the treatment of choice in patients with drug-intolerant or drug-resistant AV node reentrant tachycardia . 4 . These procedures are also recommended as alternative therapy in patients with symptomatic drug-intolerant or drug-resistant atria[, sinoatrial and ventricular tachyarrhythmias.
In all four categories, ablation is recommended as therapy in patients who desire . avoidance of long-term drug therapy . As these procedures continue to evolve they may become a treatment of choice for initial therapy or an alternative early treatment choice for many patients with these arrhythmias.
